Jung-woo Bae

Daegu, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications

The impact of CYP2D6 on donepezil concentration and its lack of effect on the treatment response and adverse effect in Korean patients with Alzheimer's disease.

The impact of CYP2D6 on donepezil concentration and its lack of effect on the treatment response and adverse effect in Korean patients with Alzheimer's disease.

Journal: The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology
Published: July 19, 2024

Effects of fluconazole on the pharmacokinetics of celecoxib and its carboxylic acid metabolite in different CYP2C9 genotypes.

Effects of fluconazole on the pharmacokinetics of celecoxib and its carboxylic acid metabolite in different CYP2C9 genotypes.

Journal: Archives of pharmacal research
Published: March 30, 2024

Physiologically based pharmacokinetic (PBPK) modeling of pitavastatin in relation to SLCO1B1 genetic polymorphism.

Physiologically based pharmacokinetic (PBPK) modeling of pitavastatin in relation to SLCO1B1 genetic polymorphism.

Journal: Archives of pharmacal research
Published: November 10, 2023

PBPK modeling to predict the pharmacokinetics of pantoprazole in different CYP2C19 genotypes.

PBPK modeling to predict the pharmacokinetics of pantoprazole in different CYP2C19 genotypes.

Journal: Archives of pharmacal research
Published: November 10, 2023

PBPK modeling to predict the pharmacokinetics of venlafaxine and its active metabolite in different CYP2D6 genotypes and drug-drug interactions with clarithromycin and paroxetine.

PBPK modeling to predict the pharmacokinetics of venlafaxine and its active metabolite in different CYP2D6 genotypes and drug-drug interactions with clarithromycin and paroxetine.

Journal: Archives of pharmacal research
Published: November 09, 2023

Physiologically based pharmacokinetic (PBPK) modeling of gliclazide for different genotypes of CYP2C9 and CYP2C19.

Physiologically based pharmacokinetic (PBPK) modeling of gliclazide for different genotypes of CYP2C9 and CYP2C19.

Journal: Archives of pharmacal research
Published: October 26, 2023

A chitosan/alginate coated nano-liposome to improve intestinal absorption of curcumin for oral administration.

A chitosan/alginate coated nano-liposome to improve intestinal absorption of curcumin for oral administration.

Journal: Food science and biotechnology
Published: May 21, 2023

Alcohol perturbed locomotor behavior, metabolism, and pharmacokinetics of gamma-hydroxybutyric acid in rats.

Alcohol perturbed locomotor behavior, metabolism, and pharmacokinetics of gamma-hydroxybutyric acid in rats.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 25, 2023

Effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of gliclazide in healthy subjects.

Effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of gliclazide in healthy subjects.

Journal: Archives of pharmacal research
Published: December 12, 2022

Effects of CYP2D6*10 allele on the pharmacokinetics of tolperisone.

Effects of CYP2D6*10 allele on the pharmacokinetics of tolperisone.

Journal: Archives of pharmacal research
Published: November 13, 2022

Physiologically based pharmacokinetic (PBPK) modeling of flurbiprofen in different CYP2C9 genotypes.

Physiologically based pharmacokinetic (PBPK) modeling of flurbiprofen in different CYP2C9 genotypes.

Journal: Archives of pharmacal research
Published: June 16, 2022

Physiologically based pharmacokinetic modelling to predict the pharmacokinetics of metoprolol in different CYP2D6 genotypes.

Physiologically based pharmacokinetic modelling to predict the pharmacokinetics of metoprolol in different CYP2D6 genotypes.

Journal: Archives of pharmacal research
Published: May 02, 2022
Showing 1-12 of 47

Last Updated: 09/26/2026